The Latin America, Middle East and Africa Pet Diabetes Care Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).
These pancreatic cells in diabetic cats and dogs either generate little to no insulin, or the insulin that is released has an aberrant effect. When this occurs, glucose could not enter the cells of the body and starts to build up in the blood. Moreover, the body's cells lack sufficient energy. The result of these two factors together is diabetes mellitus.
The cornerstone of care for diabetic canines and felines is insulin therapy, and numerous kinds of insulin have been proven to be effective. By enhancing peripheral glucose uptake and inhibiting hepatic glucose synthesis, insulin lowers blood sugar levels. By lowering the cells' glucose tolerance, insulin slows the development of beta-cell apoptosis. In cats, insulin aids in preventing the formation of amyloid plaques from the amyloid polypeptide islet. As a result, insulin is unquestionably the best treatment option for managing diabetes in canine and feline patients.
Between 2016 and 2020, the pet population in the United Arab Emirates (UAE) expanded by over 10,000 animals per year, with the number of large dogs expanding at the quickest rate, at about 6,000 animals per year. Pet "humanization" and the nation's new pet protection law, which was created to prevent pet abandonment and abuse, particularly by nomadic expats, are both driving demand for healthier goods. Between 2016 and 2020, the number of dogs and cats in the UAE increased by over 10,000 apiece, with the huge dog population expanding by about 6,000 animals at the highest rate.
The Brazil market dominated the LAMEA Pet Diabetes Care Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $57.3 million by 2028. The Argentina market is experiencing a CAGR of 14.8% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.9% during (2022 - 2028).
Based on Animal Type, the market is segmented into Dogs and Cat. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce. Based on Solution, the market is segmented into Treatment (Insulin Therapy, Insulin Delivery Devices, and Others) and Glucose Monitoring Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Pet Diabetes Care Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Merck & Co., Inc., Zoetis, Inc., ACON Laboratories, Inc., Allison Medical, Inc., i-SENS, Inc., Trividia Health, Inc., UltiMed, Inc., and Taidoc Technology Corporation.
By Animal Type
By Distribution Channel
By Solution
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 